Scott Craig

  • 301 Congress Avenue
  • Suite 900
  • Austin, Texas 78701
  • United States
Profile Experience

Scott Craig advises emerging growth, technology and life science companies and their boards of directors, as well as venture capital and private equity funds on a full range of corporate transactions in high-growth industries.

Drawing on his varied experience, Mr. Craig guides clients throughout the company life cycle, from incorporation through exit planning. He brings particular experience in the technology and life sciences sectors. Mr. Craig also advises private equity funds and their portfolio companies from initial investment through exit.

Mr. Craig provides clients with company representation on a full range of matters and transactions, including:

  • Equity financing transactions at all stages
  • Company formation
  • Mergers and acquisitions
  • Private equity
  • Corporate governance matters

Prior to law school, Mr. Craig worked for Manhattan Associates, a leading global supply-chain software company.

Representative transactions include advising:

Venture Capital and Emerging Companies 
  • Atmosphere, a worldwide leader in streaming TV entertainment for businesses, in its Series C Financing
  • A media and information services company in its Series A1 and Series B Financings*
  • A business and productivity software company in its investment from Sixth Street Growth and acquisition of Exponea*
  • A software development applications company in its Series Seed, Series A, and Series B Financings*
  • A venture capital investment firm in its investments in several early-stage investments*
  • A construction technologies company in its Series Seed, Series A, and Series A1 Financings*
  • A medical supplies company in its Series A Financing*
  • An education and training services company in its Series A1 Financing*
  • An early-stage venture capital firm in its Series A investment in Rollick and investment in AmplifAI*
  • A business and productivity software company in its Series Seed Financing*
  • A biotechnology company in its Series B1 Financing*
  • A private equity firm in its investment in Cloudhesive*
Mergers & Acquisitions and Private Equity
  • Everly Health, Inc. in its acquisitions of PWNHealth and Home Access Health*
  • A private equity firm in its majority investments in all of its current portfolio, in addition to over a dozen add-on transactions.  
  • Trax Technologies in its merger with Veraction*
  • A real estate technology company in its acquisition of StratoDem Analytics*
  • A business and productivity software company in its acquisitions of Food Sales Enablers and TABS Analytics*
  • A software company in its investment by Warburg Pincus*
  • A business and productivity software company in its acquisition of Ecrion*
  • Rackspace in its going-private transaction with Apollo*
  • A civic engagement software company in its acquisition of Primegov
  • Argo Design in its acquisition by DXC*
  • Conversable in its acquisition by LivePerson*
  • Contegix in its acquisition by Netrix*
  • Fluence Biosciences in its acquisition by OSRAM*
  • Interactive TKO in its acquisition by Computer Associates*
  • Kimbia in its acquisition by GiveGab*
  • LiquidFrameworks in its acquisition by Luminate Capital Partners*
  • M87 in its acquisition by XCOM*
  • National Instruments in its acquisitions of AWR Corporation, Phase Matrix, Digilent, BeeCube, and Data Translation*
  • Magnitude Software in its acquisition by Audax Group*
  • Microtune in its acquisition by Zoran Corporation*
  • Renew Data in its acquisition by LDiscovery*
  • Seismic Micro-Technology in its acquisition by IHS Global*
  • Sierra Atlantic in its acquisition by Hitachi Consulting*
  • Simplifi in its acquisition by GTCR*
  • Shipstation in its acquisition by*
  • Sweet Leaf Tea Company in its acquisition by Nestlé Waters North America*

*Matter handled prior to joining Latham

Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.